A Pilot Prevention Study of the Effects of the Anti-progestin Ulipristal Acetate (UA) on Surrogate Markers of Breast Cancer Risk
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Ulipristal (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms BC-APPS1
- 05 Oct 2017 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Oct 2015).
- 01 Oct 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated